Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
ADJUVANT TREATMENT OF HER2-POSITIVE BREAST CANCER

No-Receipt date 2024-00352 - 24/01/2024
No-Filing date 20240400226 - 24/01/2024
No-Granting date 3114517 - 30/01/2024
No-EPO application date 18712044.9 - 28/02/2018
No-EPO granting date 3589661 - 01/11/2023
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 1/2024 - 09/02/2024
Expiration date 01/03/2038
Kind of title Validation of European Patent
Legal status VALID
Priorities US201762466239 P02/03/2017/US
US201762469317 P09/03/2017/US
US201762486876 P18/04/2017/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
C07K 16/32
A61P 35/00
A61K 9/00
A61K 45/06
A61K 39/395
A61K 39/00

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
1576283 GENENTECH, INC. 1 DNA WAYSOUTH SAN FRANCISCO, CA 94080 UNITED STATES OF AMERICA (USA)
1576284 F. HOFFMANN-LA ROCHE AG GRENZACHERSTRASSE 1244070 BASEL SWITZERLAND

Inventors
CodeFirstnameSurname
4098720 BENYUNES, MARK, C.
4098721 ROSS, GRAHAM, ALEXANDER

Representatives
CodeFirstnameSurnameAddressTownZip
3463MARIAATHANASIADOU "ELENI G. PAPAKONSTANTINOU KAI SYNERGATES, DIKIGORIKI ETAIRIA"KOUMPARI 2ATHINA (ATTIKIS)10674

Contact
CodeFirstnameSurnameAddressTownZipCountry
848EFANGELIAGIAZITZOGLOU - THOMAIDOUKOUMPARI 2ATHINA (ATTIKIS)10674 GREECE

Owners History

Title Instruments

Payments history 8 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015